clinicals

Unfortunately this is the outcome predicted some numerous months ago. The fundamental issue of lack of clinical studies will bind the company. Until they conduct controlled clinical studies they will not be demonstrated of clinical effectiveness nor safety. When I have raised this in posts previous some posters resist this argument but it is the case and will remain the case until the necessary studies are conducted.


The 'we believe in the product because we believe in the product' thesis does not hold sway with regulators or clinicians. They want actual data. Sorry.

I have and still believe the product offers promise and initials results are interesting but will go nowhere until the company accepts reality and conducts the studies.